Svenja Litzkendorf

Svenja Litzkendorf

Auto-generated profile, based on publicly available information

Svenja Litzkendorf

Center for Health Economics Research Hannover (CHERH), Leibniz University Hannover, Hannover, Germany

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2017 in Journal of Medical Internet Research
Verified
Journal Article
Open access
FPFrédéric Pauer
Frédéric Pauer
SLSvenja Litzkendorf
Svenja Litzkendorf
JGJens Göbel
Jens Göbel
HSHolger Storf
Holger Storf
JZJan Zeidler
Jan Zeidler
JSJohann-Matthias Graf von der Schulenburg
Johann-Matthias Graf von der Schulenburg
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

LLLuz María Peña Longobardo
Luz María Peña Longobardo
IAIsaac Aranda-Reneo
Isaac Aranda-Reneo
JOJuan Oliva-Moreno
Juan Oliva-Moreno
SLSvenja Litzkendorf
Svenja Litzkendorf
IAIsabelle APHP
Isabelle APHP
JLJulio López-Bastida
Julio López-Bastida
Background: this study aimed to estimate the economic impact and health-related quality of life (HRQOL) of patients with spinal muscular atrophy (SMA) in three European countries. It was used a cross-sectional study carried out in France, Germany, and the United Kingdom. Data were collected from July 2015 to November 2015. Healthcare costs (hospitalizations, emergencies, medical tests, drugs used, visits to general practitioners (GPs) and specialists, medical material and healthcare transport), and non-healthcare costs (social services and informal care) were identified and valued. EuroQol instruments, the Zarit interview, and the Barthel Index were also used to reflect the burden and the social impact of the disease beyond the cost of healthcare. Results: we included 86 children with SMA, 26.7% of them had Type I, and 73.3% Type II or III. The annual average cost associated with SMA reaches €54,295 in the UK, €32,042 in France and €51,983 in Germany. The direct non-healthcare costs ranged between 79–86% of the total cost and the informal care costs were the main component of these costs. Additionally, people suffering from this disease have a very low health-related quality of life, and there are large differences between countries. Conclusions: SMA has a high socioeconomic impact in terms of healthcare and social costs. It was also observed that the HRQOL of affected children was extremely reduced. The figures shown in this study may help to design more efficient and equitable policies, with special emphasis on the support provided to the families or on non-healthcare aid.

5 June 2020 in BMC Public Health
Verified
Journal Article
Open access
PDF file
SLSvenja Litzkendorf
Svenja Litzkendorf
MFMartin Frank
Martin Frank
ABAna Babac
Ana Babac
DRDaniel Rosenfeldt
Daniel Rosenfeldt
FSFranziska Schauer
Franziska Schauer
JSJ.-Matthias Graf von der Schulenburg
J.-Matthias Graf von der Schulenburg
Background: Finding reliable information on one of more than 7000 rare diseases is a major challenge for those affected. Since rare diseases are defined only by the prevalence criterion, a multitude of heterogeneous diseases are included. Common to all, however, are difficulties regarding information access. Even though various quantitative studies have analyzed the use of different information sources for specific rare diseases, little is known about the use of information sources for different rare diseases, how users rate these information sources based on their experiences, and how the use and importance of these information sources change over time. Methods: Fifty-five patients with a variety of rare diseases and 13 close relatives participated in qualitative interviews. For these interviews, a semi-structured guideline was developed, piloted, and revised. Data analysis involved a qualitative content analysis developed by Philipp Mayring. Results: The participants considered internet as the most important and widespread information source, especially for early information. Although patients have difficulty dealing with information obtained online, they consider online searching a quick and practical option to gather information. During the course of the disease, personal contact partners, especially self-help associations and specialized doctors, become more important. This is also because information provided online is sometimes insufficiently detailed to answer their information needs, which can be complemented by information from doctors and self-help. Conclusions: People rarely use just one type of source, but rather refer to different sources and informants. The source used depends on the type of information sought as well as other person-related factors such as preexisting knowledge and the disease stage. To improve people’s information searching and connect them with medical specialists in rare diseases, a central information portal on rare diseases might be a suitable access point to provide free and quality assured information for patients, caregivers, and physicians. This would allow not only patients but also doctors to find quality assured information on symptoms and therapies as well as patient associations and specialized doctors.

IAIsaac Aranda-Reneo
Isaac Aranda-Reneo
LLLuz María Peña Longobardo
Luz María Peña Longobardo
JOJuan Oliva-Moreno
Juan Oliva-Moreno
SLSvenja Litzkendorf
Svenja Litzkendorf
IDIsabelle Durand-Zaleski
Isabelle Durand-Zaleski
JLJulio López-Bastida
Julio López-Bastida
Spinal muscular atrophy (SMA) is one of the most common severe hereditary diseases of infancy and early childhood. The progression of this illness causes a high degree of disability; hence, a significant burden is experienced by individuals with this disease and their families. We analyzed the time taken to care for patients suffering from SMA in European countries and the burden on their informal caregivers. We designed a cross-sectional study recording data from France, Germany, Spain and the United Kingdom. The primary caregivers completed a self-administered questionnaire that included questions about the time of care, The Zarit Burden Interview, type of SMA and socio-demographic characteristics. Multivariate analyses were used to study the associations between the type of SMA, time of care and burden supported by informal caregivers. The caregivers provided 10.0 h (SD = 6.7) per day of care (the principal caregivers provided 6.9 h, SD = 4.6). The informal caregivers of patients with type I SMA had a 36.3 point higher likelihood (p < 0.05) of providing more than 10 h of care per day in comparison with caregivers of patients with type III SMA. The severity of the disease was associated with more time of care and a higher burden on the caregivers.

25 August 2016 in Interactive Journal of Medical Research
Verified
Journal Article
Open access
FPFrédéric Pauer
Frédéric Pauer
JGJens Göbel
Jens Göbel
HSHolger Storf
Holger Storf
SLSvenja Litzkendorf
Svenja Litzkendorf
ABAna Babac
Ana Babac
THTobias Hartz
Tobias Hartz
Interactive Journal of Medical Research

9 February 2018 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
ABAna Babac
Ana Babac
MFMartin Frank
Martin Frank
FPFrédéric Pauer
Frédéric Pauer
SLSvenja Litzkendorf
Svenja Litzkendorf
DRDaniel Rosenfeldt
Daniel Rosenfeldt
JSJ-Matthias Graf von der Schulenburg
J-Matthias Graf von der Schulenburg
Rare diseases are, by definition, very serious and chronic diseases with a high negative impact on quality of life. Approximately 350 million people worldwide live with rare diseases. The resulting high disease burden triggers health information search, but helpful, high-quality, and up-to-date information is often hard to find. Therefore, the improvement of health information provision has been integrated in many national plans for rare diseases, discussing the telephone as one access option. In this context, this study examines the need for a telephone service offering information for people affected by rare diseases, their relatives, and physicians. In total, 107 individuals participated in a qualitative interview study conducted in Germany. Sixty-eight individuals suffering from a rare disease or related to somebody with rare diseases and 39 health care professionals took part. Individual interviews were conducted using a standardized semi-structured questionnaire. Interviews were analysed using the qualitative content analysis, triangulating patients, relatives, and health care professionals. The fulfilment of qualitative data processing standards has been controlled for. Out of 68 patients and relatives and 39 physicians, 52 and 18, respectively, advocated for the establishment of a rare diseases telephone service. Interviewees expected a helpline to include expert staffing, personal contact, good availability, low technical barriers, medical and psychosocial topics of counselling, guidance in reducing information chaos, and referrals. Health care professionals highlighted the importance of medical topics of counselling—in particular, differential diagnostics—and referrals. Therefore, the need for a national rare diseases helpline was confirmed in this study. Due to limited financial resources, existing offers should be adapted in a stepwise procedure in accordance with the identified attributes.